100,000 patients are admitted for ventilation in the UK critical care units each year and 10-20% will go on to develop ventilated associated pneumonia (VAP). Between 3,000 and 6,000 people die from this type of pneumonia every year and prevention would save many lives. Treating VAP costs the NHS between £10,000 – £20,000 per patient and conservative estimates for prevention are savings to the NHS of over £100 million.
The PneuX system from Venner Medical is one example of the technology available. Full details from the manufacturer are here.
Collated evidence is available on the right, courtesy of North East and North Cumbria AHSN.
An economic impact model is also available on the right, courtesy of UCL Partners. Enter your regional population to cell B4 for an estimate of lives and money saved.